Under an instrument evaluation agreement, researchers at the University of Pennsylvania will explore utilization of “MARS” platform of Applied Cells to assist in protocol development for areas of advanced cancer diagnosis and cancer treatment. Santa Clara, California – University of Pennsylvania (Penn) and Applied Cells, Inc., a Santa Clara, California based biotechnology company, announced today […]
SANTA CLARA, Calif.– Agilent Technologies Inc. (NYSE: A) is collaborating with researchers at two UK universities who are looking into the risk factors for atopic eczema (also known as atopic dermatitis), a chronic skin condition that affects one in five children and one in 12 adults. The aim of the collaboration is to help the medical […]
The partnership aligns with Civica’s strategy to make quality medications available and affordable SALT LAKE CITY, UT, January 16, 2020 – Civica Rx (Civica, Inc.) today announced it has signed a longterm agreement with Thermo Fisher Scientific to develop and manufacture medications with Civica as the owner of the regulatory pathway. By working with […]
SOUTH SAN FRANCISCO, Calif.–Jan. 15, 2020– Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, announced today a collaboration with Schrödinger, Inc., a company focused on transforming the way therapeutics are discovered with a physics-based computational platform, to bring the two companies’ […]
Astrea Bioseparations to pack CaptureSelect and POROS chromatography resins in Astrea Bioseparations’ EvolveDTM columns; Columns packed using validated methods in certified rooms supported by comprehensive regulatory support files Ballasalla, Isle of Man, British Isles – Astrea Bioseparations Ltd (Astrea), formerly Prometic Bioseparations, announced today that it has entered into a non-exclusive supply agreement with Thermo […]
Ann Arbor, Mich., and Beijing, China — Celsee, Inc., a leading provider of single-cell isolation technology, and Kindstar Global, the largest medical esoteric testing service group in China, today announced a purchase agreement to provide scientists at the Kindstar Laboratory System in China with Celsee’s Genesis System for monitoring circulating tumor cells (CTCs) in lung, […]
ANN ARBOR, Mich. — Swift Biosciences, Inc. (“Swift”), a leader in design and manufacturing of unique DNA and RNA library preparation and normalization kits for Next-Generation Sequencing (NGS), and MGI Tech Co., Ltd. (MGI), a subsidiary of BGI Group, today announced a co-marketing agreement for Swift’s DNA and RNA library preparation products in Europe and Asia Pacific markets. With […]
Next-generation gene editing system has applications in development of cell and gene therapies Base editing builds on CRISPR offering and will expand Horizon’s research tools and services Horizon seeks partners to assess and shape platform development Cambridge, UK, 14 January 2020: Horizon Discovery Group plc (LSE: HZD) (“Horizon”, “the Company” or “the Group”), a global […]
BURLINGTON, N.C. & CARLSBAD, Calif.– LabCorp® (NYSE: LH) announced it will adopt the Ion Torrent Genexus System* and Oncomine Precision Assay* for use in research and development of companion diagnostics as well as other future oncology and precision medicine applications. LabCorp will also evaluate the potential for future deployment of the system and test across […]
Genomics England and Illumina today announced a new agreement to deliver up to 300,000 whole genome equivalents over the next five years, with an option to increase to 500,000. Samples will be provided through the NHS Genomic Medicine Service and the network of seven genomic laboratory hubs across England, which were established in 2018. This supports NHS England’s ambition […]
Pay Invoice
Latest Blogs
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
